In the context of gut microbiota, Lactobacillus rhamnosus HY7207 can modulate the expression of BAX and Bcl2, thereby reducing hepatocyte apoptosis and improving NAFLD in mice [132]. The gene discussed is BCL2; the disease is metabolic dysfunction-associated steatotic liver disease.